Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1997; Volume 52,Issue 2

Accelerated Communication

  • You have access
    Activation of Type II Adenylate Cyclase by D2 and D4 but Not D3 Dopamine Receptors
    Val J. Watts and Kim A. Neve
    Molecular Pharmacology August 1997, 52 (2) 181-186; DOI: https://doi.org/10.1124/mol.52.2.181

Articles

  • You have access
    An Efficacy-Dependent Effect of Cardiac Overexpression of β2-Adrenoceptor on Ligand Affinity in Transgenic Mice
    Hakan Gürdal, Richard A. Bond, Mark D. Johnson, Eitan Friedman and H. Ongun Onaran
    Molecular Pharmacology August 1997, 52 (2) 187-194; DOI: https://doi.org/10.1124/mol.52.2.187
  • You have access
    Enhanced Apoptosis in Metallothionein Null Cells
    Yukihiro Kondo, James M. Rusnak, Dale G. Hoyt, Catherine E. Settineri, Bruce R. Pitt and John S. Lazo
    Molecular Pharmacology August 1997, 52 (2) 195-201; DOI: https://doi.org/10.1124/mol.52.2.195
  • You have access
    Determination of Aryl Hydrocarbon Receptor Nuclear Translocator Protein Concentration and Subcellular Localization in Hepatic and Nonhepatic Cell Culture Lines: Development of Quantitative Western Blotting Protocols for Calculation of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Nuclear Translocator Protein in Total Cell Lysates
    Jennifer L. Holmes and Richard S. Pollenz
    Molecular Pharmacology August 1997, 52 (2) 202-211; DOI: https://doi.org/10.1124/mol.52.2.202
  • You have access
    Differential Expression of the UGT1A Locus in Human Liver, Biliary, and Gastric Tissue: Identification ofUGT1A7 and UGT1A10 Transcripts in Extrahepatic Tissue
    Christian P. Strassburg, Karl Oldhafer, Michael P. Manns and Robert H. Tukey
    Molecular Pharmacology August 1997, 52 (2) 212-220; DOI: https://doi.org/10.1124/mol.52.2.212
  • You have access
    5-Hydroxytryptamine1A Receptor-Mediated Increases in Receptor Expression and Activation of Nuclear Factor-κB in Transfected Chinese Hamster Ovary Cells
    Daniel S. Cowen, Perry B. Molinoff and David R. Manning
    Molecular Pharmacology August 1997, 52 (2) 221-226; DOI: https://doi.org/10.1124/mol.52.2.221
  • You have access
    Arginine-Glycine-Aspartic Acid Mimics Can Identify a Transitional Activation State of Recombinant αIIbβ3 in Human Embryonic Kidney 293 Cells
    Dicky G. Abraham, Elka M. Nutt, Rodney A. Bednar, Bohumil Bednar, Robert J. Gould and Le T. Duong
    Molecular Pharmacology August 1997, 52 (2) 227-236; DOI: https://doi.org/10.1124/mol.52.2.227
  • You have access
    Localization and Functional Expression of Splice Variants of the P2X2 Receptor
    Joseph Simon, Emma J. Kidd, Fiona M. Smith, Iain P. Chessell, Ruth Murrell-Lagnado, Patrick P. A. Humphrey and Eric A. Barnard
    Molecular Pharmacology August 1997, 52 (2) 237-248; DOI: https://doi.org/10.1124/mol.52.2.237
  • You have access
    Inhibition of O6-Alkylguanine DNA-Alkyltransferase or Poly(ADP-ribose) Polymerase Increases Susceptibility of Leukemic Cells to Apoptosis Induced by Temozolomide
    Lucio Tentori, Laura Orlando, Pedro Miguel Lacal, Elena Benincasa, Isabella Faraoni, Enzo Bonmassar, Stefania D’Atri and Grazia Graziani
    Molecular Pharmacology August 1997, 52 (2) 249-258; DOI: https://doi.org/10.1124/mol.52.2.249
  • You have access
    Identification of Conserved Aromatic Residues Essential for Agonist Binding and Second Messenger Production at 5-Hydroxytryptamine2A Receptors
    B. L. Roth, M. Shoham, M. S. Choudhary and N. Khan
    Molecular Pharmacology August 1997, 52 (2) 259-266; DOI: https://doi.org/10.1124/mol.52.2.259
  • You have access
    Cimetidine and Other H2-Receptor Antagonists as Inhibitors of Human E3 Aldehyde Dehydrogenase
    Alexandra Kikonyogo and Regina Pietruszko
    Molecular Pharmacology August 1997, 52 (2) 267-271; DOI: https://doi.org/10.1124/mol.52.2.267
  • You have access
    Opioid Regulation of the Mouse δ-Opioid Receptor Expressed in Human Embryonic Kidney 293 Cells
    George Bot, Allan D. Blake, Shuixing Li and Terry Reisine
    Molecular Pharmacology August 1997, 52 (2) 272-281; DOI: https://doi.org/10.1124/mol.52.2.272
  • You have access
    Regulation of Human Neuronal Calcium Channels by G Protein βγ Subunits Expressed in Human Embryonic Kidney 293 Cells
    Lee R. Shekter, Ronald Taussig, Samantha E. Gillard and Richard J. Miller
    Molecular Pharmacology August 1997, 52 (2) 282-291; DOI: https://doi.org/10.1124/mol.52.2.282
  • You have access
    CholecystokininB Receptor from Human Jurkat Lymphoblastic T Cells Is Involved in Activator Protein-1-Responsive Gene Activation
    Catherine Oiry, Didier Gagne, Éric Cottin, Nicole Bernad, Jean-Claude Galleyrand, Gilbert Bergé, Marie-Francoise Lignon, Patrick Eldin, Martine Le Cunff, Jean Léger, Pascal Clerc, Daniel Fourmy and Jean Martinez
    Molecular Pharmacology August 1997, 52 (2) 292-299; DOI: https://doi.org/10.1124/mol.52.2.292
  • You have access
    The Reduction of α-Tocopherolquinone by Human NAD(P)H:Quinone Oxidoreductase: The Role of α-Tocopherolhydroquinone as a Cellular Antioxidant
    David Siegel, Emiko M. Bolton, Jeanne A. Burr, Daniel C. Liebler and David Ross
    Molecular Pharmacology August 1997, 52 (2) 300-305; DOI: https://doi.org/10.1124/mol.52.2.300
  • You have access
    A Mutation in the Hamster α1B-Adrenergic Receptor that Differentiates Two Steps in the Pathway of Receptor Internalization
    Jiefa Wang, Jialin Zheng, Jodi L. Anderson and Myron L. Toews
    Molecular Pharmacology August 1997, 52 (2) 306-313; DOI: https://doi.org/10.1124/mol.52.2.306
  • You have access
    Interactions of the Nonsedating Antihistamine Loratadine with a Kv1.5-Type Potassium Channel Cloned from Human Heart
    Antonio E. Lacerda, Mary-Louise Roy, Eric W. Lewis and David Rampe
    Molecular Pharmacology August 1997, 52 (2) 314-322; DOI: https://doi.org/10.1124/mol.52.2.314
  • You have access
    Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents
    Gilles Klopman, Leming M. Shi and Avner Ramu
    Molecular Pharmacology August 1997, 52 (2) 323-334; DOI: https://doi.org/10.1124/mol.52.2.323

Erratum

  • You have access
    Molecular Pharmacology August 1997, 52 (2) 335-a-335; DOI: https://doi.org/10.1124/mol.52.2.335-a

Additions and Corrections

  • You have access
    Molecular Pharmacology August 1997, 52 (2) 335-b-335; DOI: https://doi.org/10.1124/mol.52.2.335-b
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 52 (2)
Molecular Pharmacology
Vol. 52, Issue 2
1 Aug 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Erratum
  • Additions and Corrections
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics